retatrutide clinical trials update Tirzepatide vs. retatrutide peptide clinical trial Diagram
Description
Contact our team in Richmond or Prince George, Virginia, to schedule your weight loss consultation
The FDA declared the semaglutide shortage resolved in February 2025, closing the legal loophole that was allowing Hims to sell compounded semaglutide
However, a BMI in the obese range has been associated with low-grade inflammation, which could cause worse outcomes
2014;10(1 Suppl):S5561
The agency is not aware of any basis for compounding using the salt forms that would meet the FD&C requirements for types of active ingredients that can be compounded
Takeaway: The link between semaglutides, weight loss, and hair health is significant
